TECHNOLOGY AGAINST ALS FOUNDATION
EIN: 45-5365257Parsippany, NJZIP: 07054
G99 - Diseases, Disorders & Medical Disciplines501(c)(3)
Mission
FORM 990, PART III, PRIMARY EXEMPT PURPOSE- TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS WITH ALS AND LOCKED IN SYNDROME BY EXPLOITING THE LATEST TECHNOLOGIES AVAILABLE TODAY. TO DEVELOP AND DISTRIBUTE DEVICES THAT ENABLE ALS PATIENTS TO CONTROL THEIR ENVIROMENT AND TO COMMUNICATE USING ONLY THEIR EYES.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $175k | $0 | $52k |
Compensation
Similar Organizations
ACCESS ONE INC
$181k revenueSomers Point, NJ
Similar sector (G)Very similar revenue ($181k vs $175k)Same state (New Jersey)Similar size (5 vs 3 executives)
THE SAVING LIMBS FOUNDATION
$100k revenueMillville, NJ
Same sector (G99)Comparable revenue ($100k vs $175k)Same state (New Jersey)Similar size (1 vs 3 executives)
CHILDHOOD CANCER SOCIETY INC
$165k revenueWall, NJ
Similar sector (G)Very similar revenue ($165k vs $175k)Same state (New Jersey)Similar size (5 vs 3 executives)
BEATING HEARTS INC
$108k revenueNorth Caldwell, NJ
Same sector (G99)Comparable revenue ($108k vs $175k)Same state (New Jersey)Similar size (3 vs 3 executives)
HOPE FOR CHILDREN RESEARCH FOUND
$191k revenueRamsey, NJ
Similar sector (G)Very similar revenue ($191k vs $175k)Same state (New Jersey)Similar size (5 vs 3 executives)
CUREARSCUREARS a NJ Nonprofit Corporation
$182k revenueRaritan, NJ
Similar sector (G)Very similar revenue ($182k vs $175k)Same state (New Jersey)
UHMLA INC
$164k revenueBedminster, NJ
Similar sector (G)Very similar revenue ($164k vs $175k)Same state (New Jersey)
I HOPE INC
$177k revenueWest Orange, NJ
Similar sector (G)Very similar revenue ($177k vs $175k)Same state (New Jersey)
HUGS FOR BRADY FOUNDATION
$170k revenueKendall Park, NJ
Similar sector (G)Very similar revenue ($170k vs $175k)Same state (New Jersey)
RYAN'S QUEST INC
$161k revenueHamilton, NJ
Similar sector (G)Very similar revenue ($161k vs $175k)Same state (New Jersey)
Data from IRS Form 990 filings (2023).